These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19007888)

  • 1. CD8+ T cell immunity to Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.
    Hislop AD; Sabbah S
    Semin Cancer Biol; 2008 Dec; 18(6):416-22. PubMed ID: 19007888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
    Münz C
    Front Immunol; 2020; 11():581419. PubMed ID: 33013936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV infection of B cells primes protective T cell responses in humanized mice.
    Caduff N; Rieble L; Böni M; McHugh D; Roshan R; Miley W; Labo N; Barman S; Trivett M; Bosma DMT; Rühl J; Goebels N; Whitby D; Münz C
    Nat Commun; 2024 Jun; 15(1):4841. PubMed ID: 38844783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of the immune response by Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus: consequences for tumor development.
    Ressing ME; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):379-80. PubMed ID: 18992819
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal Models of Human Gammaherpesvirus Infections.
    Fujiwara S
    Adv Exp Med Biol; 2018; 1045():413-436. PubMed ID: 29896678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms in murine gammaherpesvirus-68 infection.
    Stevenson PG; Efstathiou S
    Viral Immunol; 2005; 18(3):445-56. PubMed ID: 16212523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
    Aligo J; Walker M; Bugelski P; Weinstock D
    J Immunotoxicol; 2015; 12(1):1-15. PubMed ID: 24512328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
    Orlova N; Wang F; Fogg MH
    J Virol; 2011 Dec; 85(23):12821-4. PubMed ID: 21917961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives
    Wang Y; Ungerleider N; Hoffman BA; Kara M; Farrell PJ; Flemington EK; Lee N; Tibbetts SA
    mBio; 2022 Jun; 13(3):e0083622. PubMed ID: 35642944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Are Maintained Together to Transform the Same B-Cell.
    Sugden AU; Hayes M; Sugden B
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
    Swaminathan S
    Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes.
    Bihl F; Narayan M; Chisholm JV; Henry LM; Suscovich TJ; Brown EE; Welzel TM; Kaufmann DE; Zaman TM; Dollard S; Martin JN; Wang F; Scadden DT; Kaye KM; Brander C
    J Virol; 2007 May; 81(9):4904-8. PubMed ID: 17329344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through
    Hogan CH; Owens SM; Reynoso GV; Liao Y; Meyer TJ; Zelazowska MA; Liu B; Li X; Grosskopf AK; Khairallah C; Kirillov V; Reich NC; Sheridan BS; McBride KM; Gewurz BE; Hickman HD; Forrest JC; Krug LT
    mBio; 2024 Feb; 15(2):e0299823. PubMed ID: 38170993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB signaling modulation by EBV and KSHV.
    de Oliveira DE; Ballon G; Cesarman E
    Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to Epstein-Barr virus.
    Callan MF
    Microbes Infect; 2004 Aug; 6(10):937-45. PubMed ID: 15310471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.
    Cirac A; Stützle S; Dieckmeyer M; Adhikary D; Moosmann A; Körber N; Bauer T; Witter K; Delecluse HJ; Behrends U; Mautner J
    Cancer Immunol Immunother; 2018 Apr; 67(4):663-674. PubMed ID: 29374782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.